What is AMBQ's proceeds from warrant exercises?

AMBQ (AMBQ) reported proceeds from warrant exercises of $3.01M in Q1 2026.

What does proceeds from warrant exercises mean?

This metric represents the cash inflows received by the company when holders of warrants exercise their rights to purchase common stock. It indicates a source of non-dilutive or secondary capital infusion and reflects the conversion of derivative instruments into equity. This is a key indicator of investor confidence and a source of liquidity for the company.

AMBQ AMBQ Proceeds From Warrant Exercises

Proceeds From Warrant Exercises at other companies

CleanSparkCLSK

$114K+159%

NuScale PowerSMR

$0-100%

NextNavNN

$13K-97.5%

JAN

Janus Living JAN

-$80K—

TRV

Trevi Therapeutics, Inc.TRVI

$2.54M—

GameStopGME

$53.72K—

Other financials

Income statement

See full

Revenue$25.1M+59.3%

Gross profit$10.9M+29.8%

Operating income-$11.7M-33.7%

Net income-$10.2M-22.8%

EPS (diluted)-$0.50+97.4%

Balance sheet

See full

Cash & equivalents$204.5M—

Total debt$2.1M—

Total equity$235.2M+178%

Total assets$259.5M—

Cash flow

See full

Operating cash flow-$11.2M-895%

Valuation

See full

Market cap$1.74B—

Enterprise value$1.54B—

P/S21.3×—

Profitability

See full

Gross margin42.3%+7.7pp

Operating margin-51.9%-0.5pp

Net margin-46.9%-3.0pp

Returns & leverage

See full

Return on equity118.8%—

Debt / equity0×—

Current ratio11.7×—

Where this comes from

Reported directly by AMBQ in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.

The official record: AMBQ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AMBQ's proceeds from warrant exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AMBQ's proceeds from warrant exercises?: AMBQ (AMBQ) reported proceeds from warrant exercises of $3.01M in Q1 2026.
What does proceeds from warrant exercises mean?: This metric represents the cash inflows received by the company when holders of warrants exercise their rights to purchase common stock. It indicates a source of non-dilutive or secondary capital infusion and reflects the conversion of derivative instruments into equity. This is a key indicator of investor confidence and a source of liquidity for the company.